参考文献/References:
[1] Wang W,Hu SS,Kong LZ,et al. Summary of report on cardiovascular diseases in China,2012[J].Biomed Environ Sci,2014,27(7):552-558.DOI:10. 3967 /bes2014.085.
[2] Li Y,Wang DD,Ley SH,et al. Potential impact of time trend of life-style factors on cardiovascular disease burden in China[J].J Am Coll Cardiol,2016,68(8):818-833.DOI:10.1016/j.jacc.2016.06.011.
[3] Nurdiantami Y,Watanabe K,Tanaka E,et al. Association of general and central obesity with hypertension[J].Clin Nutr,2018,37(4):1259-1263.DOI:10.1016/j. clnu. 2017. 05.012.
[4] Leggio M,Lombardi M,Caldarone E,et al. The relationship between obesity and hyperten-sion:an updated comprehensive overview on vicious twins[J].Hypertens Res,2017,40(12):947-963.DOI:10.1038/hr.2017.75.
[5] Seravalle G,Grassi G. Obesity and hypertension[J].Pharmacol Res,2017,122:1-7.DOI:10. 1016/j.phrs.2017.05.013.
[6] Zhou L,Li Y,Guo M,et al. Relations of body weight status in early adulthood and weight changes until middle age with hypertension in the Chinese population[J].Hypertens Res,2016,39(12):913-918.DOI:10.1038/hr.2016.80.
[7] Hou Y,Wang M,Yang L,et al. Weight status change from childhood to early adulthood and the risk of adult hypertension[J].J Hypertens,2019,37(6):1239-2343.DOI:10.1097/HJH.0000000000002016.
[8] Zhou Y,Xuan YJ,Yang LS,et al. Weight changes since age 20 and cardiovascular risk factors in a middle-aged Chinese population[J].J Public Health(Oxf),2018,40(2):253-261.DOI:10.1093/pubmed/fdx057.
[9] Khera R,Pandey A,Chandar AK,et al. Effects of weight-loss medications on cardiometabolic risk profiles:a systematic review and network meta-analysis[J].Gastroenterology,2018,154(5):1309-1319.e7.DOI:10.1053/j.gastro.2017.12.024.
[10] Ma C,Avenell A,Bolland M,et al. Effects of weight loss interventions for adults who are obese on mortality,cardiovascular disease,and cancer:systematic review and meta-analysis[J].BMJ,2017,359:j4849.DOI:10.1136/bmj.j4849.
[11] Yang W,Lu J,Weng J,et al; China National Diabetes and Metabolic Disorders Study Group.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1101.DOI:10.1056/NEJMoa0908292.
[12] 陈春明,孔灵芝. 中国成人超重和肥胖症预防与控制指南[M]. 北京:人民卫生出版社,2006:2-3.
[13] 中国高血压防治指南修订委员会,高血压联盟,中华医学会心血管病学分会中国医师协会高血压专业委员会,等. 中国高血压防治指南( 2018 年修订版)[J].中国心血管杂志,2019,24(1):24-56.DOI:10. 3969/j. issn. 1007-5410. 2019. 01. 002.
[14] Shihab HM,Meoni LA,Chu AY,et al. Body mass index and risk of incident hyperten -sion over the life course:the Johns Hopkins Precursors Study[J].Circulation,2012,126(25):2983-2989.DOI:10.1161 /CIRCULATIONAHA.112.117333.
[15] Hou Y,Wang M,Yang L,et al. Weight status change from childhood to early adulthood and the risk of adult hypertension[J].J Hypertens,2019,37(6):1239-1243.DOI:10.1097 /HJH. 0000000000002016.
[16] Zhao Y,Liu Y,Sun H,et al. Association of long-term dynamic change in body weight and incident hypertension:The Rural Chinese Cohort Study[J].Nutrition,2018,54:76-82.DOI:10.1016/j.nut.2018.02.020.
[17] Itoh H,Kaneko H,Kiriyama H,et al. Effect of body weight change on blood pressure in a Japanese general population with a body mass index ≥ 22 kg/m2[J].Int Heart J,2019,60(6):1381-1386.DOI:10.1536/ihj.19-314.
[18] Perry GS,Byers TE,Mokdad AH,et al. The validity of self-reports of past body weights by U.S. adults[J].Epidemiology,1995,6(1):61-66.DOI:10.1097/00001648-199501000-00012.
[19] Ingram DD,Mussolino ME. Weight loss from maximum body weight and mortality:the Third National Health and Nutrition Examination Survey Linked Mortality File[J].Int J Obes(Lond),2010,34(6):1044-1050.DOI:10.1038/ijo.2010.41.
相似文献/References:
[1]韩菲,杨立成,孙红喜,等.2型糖尿病合并不同分期慢性肾脏疾病患者的血压特点[J].国际内分泌代谢杂志,2015,(03):149.[doi:10.3760/cma.j.issn.1673-4157.2015.03.002]
Han Fei*,Yang Licheng,Sun Hongxi,et al.Characteristics of blood pressure in type 2 diabetic patients with different degree of chronic kidney disease[J].International Journal of Endocrinology and Metabolism,2015,(02):149.[doi:10.3760/cma.j.issn.1673-4157.2015.03.002]
[2]张如意 张桦 王娇 孙嘉 陈容平 杨锐 冉建民 陈宏.超重或肥胖2型糖尿病患者糖尿病足的
患病率及相关危险因素分析[J].国际内分泌代谢杂志,2015,(06):365.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.002]
Zhang Ruyi*,Zhang Hua,Wang Jiao,et al.Prevalence and risk factors for diabetic foot in overweight or obese type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(02):365.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.002]
[3]赵一璟,陈国芳,刘超.代餐饮食在肥胖和超重患者中的应用[J].国际内分泌代谢杂志,2016,36(05):323.[doi:10.3760/cma.j.issn.1673-4157.2016.05.10]
Zhao Yijing*,Chen Guofang,Liu Chao.Application of meal replacement in obese and overweight patients[J].International Journal of Endocrinology and Metabolism,2016,36(02):323.[doi:10.3760/cma.j.issn.1673-4157.2016.05.10]
[4]尹仕红.间歇性断食干预肥胖的临床研究进展[J].国际内分泌代谢杂志,2021,41(04):345.[doi:10.3760/cma.j.cn121383-20200627-06083]
Clinical research progress on intermittent fasting intervention on obesity.Clinical research progress on intermittent fasting intervention on obesity[J].International Journal of Endocrinology and Metabolism,2021,41(02):345.[doi:10.3760/cma.j.cn121383-20200627-06083]
[5]樊淑娟,代青湘.高血压与骨质疏松症相关机制研究进展[J].国际内分泌代谢杂志,2023,43(06):489.[doi:10.3760/cma.j.cn121383-20220511-05019]
Fan Shujuan,Dai Qingxiang..Research progress on the correlation mechanism between hypertension and osteoporosis[J].International Journal of Endocrinology and Metabolism,2023,43(02):489.[doi:10.3760/cma.j.cn121383-20220511-05019]
[6]涂梦琴,廖云艳,宋颖,等.常见内分泌高血压的筛查要点[J].国际内分泌代谢杂志,2023,43(06):508.[doi:10.3760/cma.j.cn121383-20230128-01033]
Tu Mengqin,Liao Yunyan,Song Ying,et al.Key points for screening common endocrine hypertensions[J].International Journal of Endocrinology and Metabolism,2023,43(02):508.[doi:10.3760/cma.j.cn121383-20230128-01033]